Log In
BCIQ
Print this Print this
 

NCX 667

  Manage Alerts
Collapse Summary General Information
Company Nicox S.A.
DescriptionNitric oxide (NO)-donor
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationGlaucoma
Indication DetailsTreat glaucoma and ocular hypertension
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today